PRESS RELEASE published on 05/25/2023 at 07:30, 2 years 6 months ago BRAIN Biotech AG stays on solid growth path with H1 results and accelerates One-BioProducts strategy
PRESS RELEASE published on 05/24/2023 at 09:30, 2 years 6 months ago BRAIN Biotech AG gains full ownership of Biocatalysts Ltd and accelerates execution of its One-BioProducts Strategy
PRESS RELEASE published on 03/08/2023 at 17:20, 2 years 9 months ago Resolutions of the Annual General Meeting 2023 on the Financial Year 2021/2022 of BRAIN Biotech AG
PRESS RELEASE published on 02/27/2023 at 16:00, 2 years 9 months ago Capital Markets Day 2023: BRAIN Biotech AG to build an international multi-niche enzyme and food ingredients champion
PRESS RELEASE published on 02/27/2023 at 07:30, 2 years 9 months ago BRAIN Biotech AG with Strong Start into Fiscal Year 2022/23, 3M Reporting
PRESS RELEASE published on 02/22/2023 at 14:00, 2 years 9 months ago BRAIN Biotech and TransCode Therapeutics join forces to develop a CRISPR-derived technology platform for cancer treatment
PRESS RELEASE published on 02/10/2023 at 11:04, 2 years 10 months ago EQS-Adhoc: BRAIN Biotech AG terminates contract for natural sweetener solution with Roquette Frères
PRESS RELEASE published on 01/16/2023 at 07:30, 2 years 10 months ago BRAIN Biotech AG reports record figures in fiscal year 2021/22 − despite challenging geopolitical environment
PRESS RELEASE published on 01/10/2023 at 12:15, 2 years 11 months ago BRAIN Biotech AG: BRAIN Group's Akribion Genomics business will prioritize the development of therapeutic applications within its CRISPR technology platform
PRESS RELEASE published on 01/10/2023 at 12:10, 2 years 11 months ago EQS-Adhoc: BRAIN Biotech AG: prioritizing development of therapeutic applications of the Akribion Genomics technology platform (genome-editing)
Published on 12/15/2025 at 15:00, 26 minutes ago Kingfisher Reports Annual General Meeting Voting Results
Published on 12/15/2025 at 15:00, 26 minutes ago Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Published on 12/15/2025 at 14:30, 56 minutes ago Unusual Machines Congratulates Customers Selected for the Army's PBAS Tranche 1.1, Including Envision Technology and Strategic Logix
Published on 12/15/2025 at 14:00, 1 hour 26 minutes ago Dateline Delivers Further High-Grade Intercepts from North Pipe at Colosseum
Published on 12/15/2025 at 13:30, 1 hour 56 minutes ago Greenlane Announces Results of Annual Meeting of Stockholders, Canopy Growth Co Founder Bruce Linton Joins Greenlane's Board of Directors
Published on 12/15/2025 at 15:14, 12 minutes ago Edison issues report on Aberdeen Asian Income Fund (AAIF)
Published on 12/15/2025 at 15:00, 26 minutes ago Partners Group’s announcement of AuM as of 31 December 2025
Published on 12/15/2025 at 14:56, 30 minutes ago EQS-Adhoc: Wolford AG: Mandate of Ralf Polito as Member of the Management Board extended
Published on 12/15/2025 at 13:35, 1 hour 51 minutes ago DeFi Technologies Announces Launch of Brazilian Depositary Receipts for Institutional Investors on B3 Exchange
Published on 12/15/2025 at 11:50, 3 hours 36 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of November 30, 2025
Published on 12/12/2025 at 18:00, 2 days 21 hours ago Disclosure of trading in own shares between November 24th and November 28th, 2025
Published on 12/11/2025 at 08:30, 4 days 6 hours ago Edenred and Daimler Truck join forces to accelerate the rollout of charging infrastructure for electric trucks in Europe
